What the analyst said
JPMorgan analyst Harlan Sur raised the price target on NVIDIA (NASDAQ: NVDA) to $230.00 (from $215.00) while maintaining an Overweight rating.
“Amidst all the noise and persistent headlines over the past two weeks, NVIDIA Corporation (NVDA) delivered a solid set of F3Q results with a strong F4Q guide that came in well ahead of consensus expectations (~5% beat) and slightly ahead of the buyside client expectations we had heard coming into the quarter (~1% above).
More importantly (and rather surprisingly), the company raised its FY28 revenue growth outlook, with the team now guiding for ~75% Y/Y growth (up from ~70% prior) off what is now a higher FY27 base, citing both sustained demand and incremental supply support from its partners (this implies total revs could reach ~$741B in FY28, ~6% above consensus estimates).
Strength in the quarter itself was primarily driven by the Vera Rubin ramp, which added ~$20B of revenue in its first full quarter of shipments (fastest product ramp in NVDA’s history) and pulled forward the reacceleration in the co’s hyperscale business a quarter earlier than management had expected.
On gross margins, management reaffirmed F4Q as the trough (71-72%) and indicated that GMs would improve to the 72-73% range in FY28, underpinned by supply commitments. On leadership, the Board confirmed that Jensen Huang would not be reinstated and that the search for a permanent CEO was underway, with interim CEO Colette Kress emphasizing that the company’s product roadmap remains on track (Vera Rubin Ultra on track for next year with Feynman slated for 2028).
Although management has navigated a difficult backdrop admirably, we think three key points remain outstanding: (1) NVDA has halted licensed Hopper shipments to China and excluded China from its outlook, but that doesn’t necessarily resolve the regulatory overhang risk, as the ongoing investigations are likely to extend well beyond China (given the focus on diversion);
(2) management didn’t clearly address financing / DC buildout risks for CY28, with the team striking a more measured tone on ecosystem financing and noting that allocation now hinges on customer land / power / shell readiness;
(3) execution remains a key risk, as delivering on an annual product cadence, scaling the supply chain, and retaining top talent is a difficult task for any company, let alone one in the midst of a leadership transition.
All told, the near-term outlook remains strong, and while the company’s roadmap remains on track, the question of who will lead the company through that roadmap (and beyond it) remains open. When you combine that with all the headline / regulatory risks (CEO search, execution risk, probes from the SEC and DoJ, etc.), we think there’s a strong case to be made that shares will remain highly volatile in the near-term.
Nonetheless, on the back of tonight’s results and management’s stronger near-to-mid-term outlook, we are raising our estimates and adjusting our PT slightly higher to $230 (up from $215 prior). Maintain OW.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
NVDA trades at $152. The 38 analysts who set a target in the last 3 months range from $135 to $515, with a median of $228. This $230 target is 1% above the median.
12-month window: day 0 of 365, closes on November 18, 2027.
Track record
This callOpen: a 12-month target, scored on November 18, 2027, a year after the note.
Firm track recordJP Morgan: 72% of its 36 targets at least a year old were reached within 12 months (#22 of 29 firms); on NVIDIA, 3 of 3. Accuracy ranking →
JP Morgan on NVIDIA
JP Morgan price targets on NVIDIA
4 calls from May 21, 2026 to November 18, 2026. The target went from $280 to $230 (−18%). The rating stayed Buy.
- November 18, 2026 This noteTarget cut from $320 (−28%)Buy$230
- September 2, 2026Kept the $320 targetBuy$320
- August 27, 2026Target raised from $280 (+14%)Buy$320
- May 21, 2026Earliest call shownBuy$280





